ID Medical Group Limited - Limited company accounts 16.3

ID Medical Group Limited - Limited company accounts 16.3


IRIS Accounts Production v17.2.1.52 03829536 Board of Directors 1.1.16 31.12.16 31.12.16 continuation and further development and expansion of its recruitment services related to the provision of staff to the healthcare industry, including hospitals within the UK. true false true true false false false true false Ordinary 0.02000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure038295362015-12-31038295362016-12-31038295362016-01-012016-12-31038295362014-12-31038295362015-01-012015-12-31038295362015-12-3103829536ns15:EnglandWales2016-01-012016-12-3103829536ns14:PoundSterling2016-01-012016-12-3103829536ns10:Director12016-01-012016-12-3103829536ns10:PrivateLimitedCompanyLtd2016-01-012016-12-3103829536ns10:FRS1022016-01-012016-12-3103829536ns10:Audited2016-01-012016-12-3103829536ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2016-01-012016-12-3103829536ns10:LargeMedium-sizedCompaniesRegimeForAccounts2016-01-012016-12-3103829536ns10:FullAccounts2016-01-012016-12-310382953612016-01-012016-12-3103829536ns10:OrdinaryShareClass22016-01-012016-12-3103829536ns10:Director22016-01-012016-12-3103829536ns10:Director32016-01-012016-12-3103829536ns10:Director42016-01-012016-12-3103829536ns10:Director52016-01-012016-12-3103829536ns10:Director62016-01-012016-12-3103829536ns10:CompanySecretary12016-01-012016-12-3103829536ns10:RegisteredOffice2016-01-012016-12-3103829536ns5:CurrentFinancialInstruments2016-12-3103829536ns5:CurrentFinancialInstruments2015-12-3103829536ns5:Non-currentFinancialInstruments2016-12-3103829536ns5:Non-currentFinancialInstruments2015-12-3103829536ns5:ShareCapital2016-12-3103829536ns5:ShareCapital2015-12-3103829536ns5:RetainedEarningsAccumulatedLosses2016-12-3103829536ns5:RetainedEarningsAccumulatedLosses2015-12-3103829536ns5:ShareCapital2014-12-3103829536ns5:RetainedEarningsAccumulatedLosses2014-12-3103829536ns5:RetainedEarningsAccumulatedLosses2015-01-012015-12-3103829536ns5:RetainedEarningsAccumulatedLosses2016-01-012016-12-3103829536ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2016-01-012016-12-310382953612016-01-012016-12-3103829536ns15:UnitedKingdom2016-01-012016-12-3103829536ns15:UnitedKingdom2015-01-012015-12-3103829536ns15:Europe2016-01-012016-12-3103829536ns15:Europe2015-01-012015-12-3103829536ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2016-01-012016-12-3103829536ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2015-01-012015-12-3103829536132016-01-012016-12-3103829536132015-01-012015-12-3103829536ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2015-12-3103829536ns5:ComputerSoftware2015-12-3103829536ns5:ComputerSoftware2016-01-012016-12-3103829536ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2016-12-3103829536ns5:ComputerSoftware2016-12-3103829536ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2015-12-3103829536ns5:ComputerSoftware2015-12-3103829536ns5:LandBuildingsns5:ShortLeaseholdAssets2015-12-3103829536ns5:FurnitureFittings2015-12-3103829536ns5:ComputerEquipment2015-12-3103829536ns5:LandBuildingsns5:ShortLeaseholdAssets2016-01-012016-12-3103829536ns5:FurnitureFittings2016-01-012016-12-3103829536ns5:ComputerEquipment2016-01-012016-12-3103829536ns5:LandBuildingsns5:ShortLeaseholdAssets2016-12-3103829536ns5:FurnitureFittings2016-12-3103829536ns5:ComputerEquipment2016-12-3103829536ns5:LandBuildingsns5:ShortLeaseholdAssets2015-12-3103829536ns5:FurnitureFittings2015-12-3103829536ns5:ComputerEquipment2015-12-3103829536ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-12-3103829536ns5:CurrentFinancialInstrumentsns5:WithinOneYear2015-12-3103829536ns5:BetweenTwoFiveYearsns5:Non-currentFinancialInstruments2016-12-3103829536ns5:BetweenTwoFiveYearsns5:Non-currentFinancialInstruments2015-12-3103829536ns5:WithinOneYear2016-12-3103829536ns5:WithinOneYear2015-12-3103829536ns5:BetweenOneFiveYears2016-12-3103829536ns5:BetweenOneFiveYears2015-12-3103829536ns5:MoreThanFiveYears2016-12-3103829536ns5:MoreThanFiveYears2015-12-3103829536ns5:AllPeriods2016-12-3103829536ns5:AllPeriods2015-12-3103829536ns5:DeferredTaxation2015-12-3103829536ns5:DeferredTaxation2016-12-3103829536ns10:OrdinaryShareClass22016-12-3103829536ns5:RetainedEarningsAccumulatedLosses2015-12-310382953612016-01-012016-12-310382953612016-01-012016-12-31


REGISTERED NUMBER: 03829536 (England and Wales)








ID MEDICAL GROUP LIMITED

STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2016






ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 December 2016










Page

Company Information 1

Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Statement of Comprehensive Income 8

Balance Sheet 9

Statement of Changes in Equity 10

Cash Flow Statement 11

Notes to the Cash Flow Statement 12

Notes to the Financial Statements 13


ID MEDICAL GROUP LIMITED

COMPANY INFORMATION
for the year ended 31 December 2016







DIRECTORS: Dr M H A Sacoor
M Sacoor
D R Patel
D S Newton
R S Nandha
D J Bruce





SECRETARY: M Sacoor





REGISTERED OFFICE: ID House
1 Mill Square
Wolverton Mill South
Milton Keynes
MK12 5ZD





REGISTERED NUMBER: 03829536 (England and Wales)





AUDITORS: Bessler Hendrie
Chartered Accountants
Statutory Auditor
Albury Mill
Mill Lane
Chilworth
Guildford
Surrey
GU4 8RU

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

STRATEGIC REPORT
for the year ended 31 December 2016


The directors present their strategic report for the year ended 31 December 2016.

REVIEW OF BUSINESS
During the year under review, the company continued, developed and expanded its principal activities, which
consist of the provision of recruitment services to the healthcare industry, namely the provision of Doctors,
Nurses and Allied Health Professionals (AHP) to hospitals within the UK.

The results for the year and financial position of the company as at the year end are as shown in the annexed
financial statements.

Key performance indicators
The directors consider that gross profit and operating profit are the key performance measures in monitoring
and managing the business.

The turnover for the year ended 31 December 2016 was £126.7m (2015: £165.1m). Gross profit was £23.9m
(2015: £26.3m) and operating profit was £1.8m (2015: £4.0m). The directors are satisfied with the results of the
company for the year in the context of the current economic conditions and given the further investment which
has been made for the benefit of future years.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors regularly review the risks pertinent to the company. The principal risks can be broadly grouped
into those related to the economic environment, those related to liquidity and those related to the supply of
locums.

Economic environment risks
The company operates in a sector which is largely dependent upon government funding. In order to reduce the
national deficit the government has continued to focus on costs. The company is proud to work in partnership
with its clients. These partnerships include the provision of services under government frameworks. The
company's appointment to national frameworks assures partnering clients of the company's capability to drive
cost-efficiencies whilst delivering totally sustainable workforce planning. This is one such example of the
company's ability to deliver added value to its client base.

Liquidity risks
This is managed proactively by ensuring that short and medium term cash flow forecasts are supported by
appropriate debt facilities. The company uses invoice discounting to finance the ongoing working capital.

Supply of temporary workers
Demand for both doctors, nurses and AHP's continues and the company has developed its recruitment program
accordingly.

Financial Risks
The directors regularly review future forecasts with specific focus on funding requirements to ensure adequate
financing is available to support future plans.


ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

STRATEGIC REPORT
for the year ended 31 December 2016

FUTURE DEVELOPMENTS
The company will continue to invest in its divisions (doctors, nurses, AHP) with a view to building upon its strong
foundations, adding client value and partnering both nationally and internationally. The Company has opened an
office in India to make use of cost-effective resource available with the dual aim of driving UK growth and
managing the company cost base in the medium term.

ON BEHALF OF THE BOARD:





D J Bruce - Director


22 September 2017

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

REPORT OF THE DIRECTORS
for the year ended 31 December 2016


The directors present their report with the financial statements of the company for the year ended 31 December 2016.

DIVIDENDS
The total distribution of dividends for the year ended 31 December 2016 was £1,400,000.

EVENTS SINCE THE END OF THE YEAR
Information relating to events since the end of the year is given in the notes to the financial statements.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2016 to the date of
this report.

Dr M H A Sacoor
M Sacoor
D R Patel
D S Newton
R S Nandha

Other changes in directors holding office are as follows:

D J Bruce - appointed 1 November 2016

EMPLOYEE INVOLVEMENT
The company regularly holds meetings at various levels (e.g. senior management meetings, departmental
meetings etc.) to encourage employee involvement and contribution. Employees are also kept well-informed
about the progress and position of the company by means of both these meetings and by other
communications, as appropriate.

EMPLOYMENT OF DISABLED PERSONS
The company's policy is to give full and fair consideration to applicants for employment made by disabled
persons, having regard to their particular aptitudes and abilities. Disabled employees receive appropriate
training to promote their career development within the company. Employees who become disabled are
retained in their existing posts where possible or retained for suitable alternative posts.

DISCLOSURE IN THE STRATEGIC REPORT
As permitted by Section 414C(11) of the Companies Act 2006 certain matters which are required to be disclosed
in the report of the directors' have been omitted as they are included in the strategic report on pages 2 to 3.
These matters relate to the principal activity and future developments of the company.


ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

REPORT OF THE DIRECTORS
for the year ended 31 December 2016

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial
statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the
directors have elected to prepare the financial statements in accordance with United Kingdom Generally
Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law
the directors must not approve the financial statements unless they are satisfied that they give a true and fair
view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing
these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- state whether applicable accounting standards have been followed, subject to any material departures
disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the
company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain
the company's transactions and disclose with reasonable accuracy at any time the financial position of the
company and enable them to ensure that the financial statements comply with the Companies Act 2006. They
are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the
prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the
Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps
that he ought to have taken as a director in order to make himself aware of any relevant audit information and
to establish that the company's auditors are aware of that information.

AUDITORS
The auditor, Bessler Hendrie, Chartered Accountants, has indicated a willingness to continue in office.

ON BEHALF OF THE BOARD:





D J Bruce - Director


22 September 2017

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ID MEDICAL GROUP LIMITED


We have audited the financial statements of ID Medical Group Limited for the year ended 31 December 2016 on
pages eight to twenty four. The financial reporting framework that has been applied in their preparation is
applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting
Practice), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and
Republic of Ireland'.

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members
those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the
fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company
and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Respective responsibilities of directors and auditors
As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's (APB's) Ethical Standards for Auditors.

Scope of the audit of the financial statements
A description of the scope of an audit of financial statements is provided on the FRC's website at
www.frc.org.uk/auditscopeukprivate.


Opinion on financial statements
In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2016 and of its profit for the
year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice;
and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Opinion on other matter prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit, the information given in the Strategic
Report and the Report of the Directors for the financial year for which the financial statements are prepared is
consistent with the financial statements, and has been prepared in accordance with applicable legal
requirements. In the light of the knowledge and understanding of the company and its environment, we have
not identified any material misstatements in the Strategic Report or the Report of the Directors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ID MEDICAL GROUP LIMITED


Matters on which we are required to report by exception
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to
report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received
from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.




Jason Saunders (Senior Statutory Auditor)
for and on behalf of Bessler Hendrie
Chartered Accountants
Statutory Auditor
Albury Mill
Mill Lane
Chilworth
Guildford
Surrey
GU4 8RU

22 September 2017

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

STATEMENT OF COMPREHENSIVE INCOME
for the year ended 31 December 2016

2016 2015
Notes £    £   

TURNOVER 3 126,745,680 165,064,493

Cost of sales (102,841,607 ) (138,790,364 )
GROSS PROFIT 23,904,073 26,274,129

Administrative expenses (22,184,727 ) (22,358,927 )
1,719,346 3,915,202

Other operating income 62,880 63,505
OPERATING PROFIT 6 1,782,226 3,978,707

Interest receivable and similar income 986 764
1,783,212 3,979,471

Interest payable and similar expenses 8 (293,500 ) (356,945 )
PROFIT BEFORE TAXATION 1,489,712 3,622,526

Tax on profit 9 (302,115 ) (748,637 )
PROFIT FOR THE FINANCIAL YEAR 1,187,597 2,873,889

OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

1,187,597

2,873,889

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

BALANCE SHEET
31 December 2016

2016 2015
Notes £    £   
FIXED ASSETS
Intangible assets 11 404,742 530,665
Tangible assets 12 785,067 975,317
Investments 13 21,002 2
1,210,811 1,505,984

CURRENT ASSETS
Stocks 14 4,302 8,370
Debtors 15 27,394,169 33,591,902
Cash at bank and in hand 413,593 754,807
27,812,064 34,355,079
CREDITORS
Amounts falling due within one year 16 (25,500,019 ) (31,985,343 )
NET CURRENT ASSETS 2,312,045 2,369,736
TOTAL ASSETS LESS CURRENT LIABILITIES 3,522,856 3,875,720

CREDITORS
Amounts falling due after more than one
year

17

(174,527

)

(286,988

)

PROVISIONS FOR LIABILITIES 20 (54,000 ) (82,000 )
NET ASSETS 3,294,329 3,506,732

CAPITAL AND RESERVES
Called up share capital 21 100 100
Retained earnings 22 3,294,229 3,506,632
SHAREHOLDERS' FUNDS 3,294,329 3,506,732

The financial statements were approved by the Board of Directors on 22 September 2017 and were signed on its
behalf by:





D J Bruce - Director


ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

STATEMENT OF CHANGES IN EQUITY
for the year ended 31 December 2016

Called up
share Retained Total
capital earnings equity
£    £    £   

Balance at 1 January 2015 100 1,902,743 1,902,843

Changes in equity
Dividends - (1,270,000 ) (1,270,000 )
Total comprehensive income - 2,873,889 2,873,889
Balance at 31 December 2015 100 3,506,632 3,506,732

Changes in equity
Dividends - (1,400,000 ) (1,400,000 )
Total comprehensive income - 1,187,597 1,187,597
Balance at 31 December 2016 100 3,294,229 3,294,329

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

CASH FLOW STATEMENT
for the year ended 31 December 2016

2016 2015
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 6,818,752 (425,407 )
Finance costs paid (293,500 ) (356,945 )
Tax paid (682,430 ) (675,387 )
Net cash from operating activities 5,842,822 (1,457,739 )

Cash flows from investing activities
Purchase of intangible fixed assets (194,400 ) (361,426 )
Purchase of tangible fixed assets (158,404 ) (858,474 )
Purchase of fixed asset investments (21,000 ) -
Interest received 986 764
Net cash from investing activities (372,818 ) (1,219,136 )

Cash flows from financing activities
New loans/(repayments) of loans (4,352,051 ) 4,536,180
Loans from/(to) directors (59,167 ) (5,030 )
Equity dividends paid (1,400,000 ) (1,270,000 )
Net cash from financing activities (5,811,218 ) 3,261,150

(Decrease)/increase in cash and cash equivalents (341,214 ) 584,275
Cash and cash equivalents at beginning
of year

2

754,807

170,532

Cash and cash equivalents at end of year 2 413,593 754,807

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE CASH FLOW STATEMENT
for the year ended 31 December 2016


1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS
2016 2015
£    £   
Profit before taxation 1,489,712 3,622,526
Depreciation charges 665,104 644,533
Loss on disposal of fixed assets 3,873 -
Finance costs 293,500 356,945
Finance income (986 ) (764 )
2,451,203 4,623,240
Decrease/(increase) in stocks 4,068 (8,370 )
Decrease/(increase) in trade and other debtors 6,256,900 (4,429,340 )
Decrease in trade and other creditors (1,893,419 ) (610,937 )
Cash generated from operations 6,818,752 (425,407 )

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect
of these Balance Sheet amounts:

Year ended 31 December 2016
31.12.16 1.1.16
£    £   
Cash and cash equivalents 413,593 754,807
Year ended 31 December 2015
31.12.15 1.1.15
£    £   
Cash and cash equivalents 754,807 170,532

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 December 2016


1. STATUTORY INFORMATION

ID Medical Group Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information
page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 (FRS
102) "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies
Act 2006. Unless indicated otherwise in the accounting policies below, the financial statements have been
prepared under the historical cost convention.

The financial statements are prepared on a going concern basis as the directors consider this to be
appropriate given the anticipated ongoing profitability of the business and on the basis that the company
has sufficient financial resources which will allow the company to manage its business risks in the
foreseeable future.

The company has taken advantage of the following disclosure exemption in preparing these financial
statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic
of Ireland":

the requirements of Section 11 Financial Instruments paragraphs 11.40 to 11.48(a).

Preparation of consolidated financial statements
The company accounts present information about it as an individual undertaking. The company is exempt
under section 402 of the Companies Act 2006 from the requirements to prepare consolidated financial
statements as the subsidiary undertakings are not material for the purpose of giving a true and fair view.

Significant judgements and estimates
The directors have made judgements and estimates in relation to accrued income, together with related
accrued cost of sales, at the year end. Further detail is provided in the turnover and income recognition
policy below.

Turnover and income recognition
Turnover represents the fair value of consideration receivable for the sale of services in the ordinary
course of the business, excluding Value Added Tax. This includes the following:

1. Turnover from temporary placements which represents amounts billed to customers for the services
performed. This is recognised when the services are provided to the customer.

2. Turnover from permanent placements which is recognised at the date when a candidate commences
work.


ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


2. ACCOUNTING POLICIES - continued

Turnover and income recognition - continued
For temporary placements, invoices are raised to customers after receipt of the timesheet from
candidates. A provision for accrued income is recognised in the financial statements for outstanding
timesheets not yet received from candidates and thus not yet billed to customers at the year end. This
provision is calculated based on the company's best estimate of the value of timesheets to be received,
which takes into account the anticipated sales value but is discounted to allow for the possibility that
turnover may not be invoiced for timesheets not received.

Intangible fixed assets
Intangible fixed assets include the following:

1. Website development costs which are capitalised where a return on investment can reasonably be
regarded as assured.

2. Computer software, where this is separately identifiable from assets of a tangible nature.

Amortisation is provided at an annual rate of 33% on cost in order to write off the cost of each asset over
its estimated useful life.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated
useful life.
Short leasehold improvements - Over the period of the lease
Office equipment - 33% or 20% on cost
Computer equipment - 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost, using the first in first out method, and estimated selling price less
costs to sell.

Taxation
Current tax is the amount of corporation tax payable in respect of the taxable profit for the year or prior
years. Tax is calculated on the basis of tax rates and laws that have been enacted or substantively enacted
by the period end.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
balance sheet date where transactions or events that result in an obligation to pay more tax in the future
or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences are
differences between the company's taxable profits and its results as stated in the financial statements.

Deferred tax is measured at the average tax rates that are expected to apply in the periods in which
timing differences are expected to reverse, based on tax rates and laws that have been enacted or
substantially enacted by the balance sheet date. Deferred tax is measured on a non-discounted basis.

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange
ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating
result.

Pension costs and other post-retirement benefits
The company operates a defined contribution scheme. The amount charged to the statement of
comprehensive income in respect of pension costs and other post retirement benefits is the contributions
payable in the year. Differences between contributions payable in the year and contributions actually
paid are shown as either accruals or prepayments in the balance sheet.

Invoice discounting
The company uses invoice discounting to obtain finance in respect of trade debts issued to non-related
companies. The company has full recourse for the debts. Invoice discounting costs are charged to the
statement of comprehensive income for the period to which they relate.

Operating leases
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership
remain with the lessor are charged to the statement of comprehensive income as incurred. The benefits
of lease incentives are recognised in the statement of comprehensive income over the life of the lease.

Fixed asset investments
Fixed asset investments are stated at cost less provisions for diminution in value.

Financial Instruments
Basic financial instruments are recognised at amortised cost.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by geographical market is given below:

2016 2015
£    £   
United Kingdom 126,740,473 164,756,776
Europe 5,207 307,717
126,745,680 165,064,493

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


4. EMPLOYEES AND DIRECTORS
2016 2015
£    £   
Wages and salaries 15,530,779 15,757,780
Social security costs 1,579,725 1,623,149
Other pension costs 78,444 70,136
17,188,948 17,451,065

The average monthly number of employees during the year was as follows:
2016 2015

Administration 165 124
Marketing 11 11
Sales 318 358
494 493

The staff costs shown above are net of recharges made to Recruitment Express Limited and Group 24
Limited for salaries, social security and pension costs of £1,180,210 (2015: £1,627,417), £116,458 (2015:
£164,067) and £5,892 (2015: £7,324) respectively.

The pension costs relate to contributions payable into a defined contribution scheme. At the year end,
contributions of £2,363 (2015: £501) were payable to the fund.

5. DIRECTORS' EMOLUMENTS

2016 2015
£
Directors' remuneration 1,579,746 2,093,166

Information regarding the highest paid director is as follows:

Emoluments etc 815,211 1,158,052

During the year, 3 (2015: 3) directors were accruing retirement benefits under a defined contribution
scheme. The total directors' pension contributions during the year amounted to £1,110 (2015: £1,093), of
which £370 (2015: £364) relates to the highest paid director.

The highest paid director did not exercise any share options during the year.

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


6. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

20162015
££
Depreciation - owned assets344,781356,108
Loss on disposal of fixed assets3,873-
Amortisation of intangible assets 320,323288,425
Foreign exchange differences5,532(1,301)
Operating leases - land and buildings 426,092350,400
Operating leases - cars35,90655,449

7. AUDITORS' REMUNERATION

2016 2015
£ £
Audit fees 16,453 15,076
Tax compliance fees 4,977 5,132
Other non-audit fees 18,986 15,491
40,416 35,699

8. INTEREST PAYABLE AND SIMILAR EXPENSES
2016 2015
£    £   
Bank loan interest 4,200 6,009
Invoice discounting interest 289,300 350,936
293,500 356,945

9. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2016 2015
£    £   
Current tax:
UK corporation tax 335,000 700,000
Prior year adjustment (4,885 ) (6,613 )
Total current tax 330,115 693,387

Deferred tax (28,000 ) 55,250
Tax on profit 302,115 748,637

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


9. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference
is explained below:

2016 2015
£    £   
Profit before tax 1,489,712 3,622,526
Profit multiplied by the standard rate of corporation tax in the UK of
20% (2015 - 20.250%)

297,942

733,562

Effects of:
Expenses not deductible for tax purposes 5,482 19,433
Adjustments to tax charge in respect of previous periods (4,885 ) (6,613 )
Rounding of tax provision 3,576 2,255
Total tax charge 302,115 748,637

10. DIVIDENDS

The aggregate dividends paid during the year totalled £1,400,000 (2015: £1,270,000).

11. INTANGIBLE FIXED ASSETS
Website
development Computer
costs software Totals
£    £    £   
COST
At 1 January 2016 171,958 1,481,722 1,653,680
Additions 1,404 192,996 194,400
At 31 December 2016 173,362 1,674,718 1,848,080
AMORTISATION
At 1 January 2016 165,550 957,465 1,123,015
Amortisation for year 4,543 315,780 320,323
At 31 December 2016 170,093 1,273,245 1,443,338
NET BOOK VALUE
At 31 December 2016 3,269 401,473 404,742
At 31 December 2015 6,408 524,257 530,665

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


12. TANGIBLE FIXED ASSETS
Short
leasehold Office Computer
improvements equipment equipment Totals
£    £    £    £   
COST
At 1 January 2016 324,744 837,380 981,370 2,143,494
Additions 435 96,979 60,990 158,404
Disposals - - (4,357 ) (4,357 )
At 31 December 2016 325,179 934,359 1,038,003 2,297,541
DEPRECIATION
At 1 January 2016 268,275 283,340 616,562 1,168,177
Charge for year (19,694 ) 171,777 192,698 344,781
Eliminated on disposal - - (484 ) (484 )
At 31 December 2016 248,581 455,117 808,776 1,512,474
NET BOOK VALUE
At 31 December 2016 76,598 479,242 229,227 785,067
At 31 December 2015 56,469 554,040 364,808 975,317

13. FIXED ASSET INVESTMENTS

Interests in
group
undertakings
£
COST
At 1 January 20162
Additions21,000
At 31 December 201621,002

NET BOOK VALUE
At 31 December 201621,002
At 31 December 20152




ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


13. FIXED ASSET INVESTMENTS - continued

The company's fixed asset investments at the balance sheet date include the following:



Aggregate capital
and reserves
Class of%20162015
CompanysharesHolding££

ID Medical LimitedOrdinary100.0011
ID Search & Selection LimitedOrdinary100.0011
22

The above companies are dormant and registered at ID House, 1 Mill Square, Featherstone Road,
Wolverton Mill, Milton Keynes, MK12 5ZD.

Capital contribution
%20162015
Limited Liability PartnershipOwnership££

ID Medical India LLP98.9021,000-

The above entity was set up shortly before the balance sheet date to provide administrative services to
the company. The entity is registered at Unit 211, Second Floor, Tower 2 World Trade Center, Kharadi,
Pune, MH 411014 IN.

14. STOCKS
2016 2015
£    £   
Restaurant stock 4,302 8,370

15. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2016 2015
£    £   
Trade debtors 20,166,609 25,235,291
Amounts owed by group undertakings 173,342 -
Amounts owed by related companies 214,625 34,722
Other debtors 224,300 139,556
Directors' loan accounts 117,908 58,741
Prepayments and accrued income 6,497,385 8,123,592
27,394,169 33,591,902

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


16. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2016 2015
£    £   
Bank loans (see note 18) 15,154,290 19,393,880
Trade creditors 1,291,602 792,815
Amounts owed to related companies 1,063,070 163,654
Tax 45,685 398,000
Social security and other taxes 3,459,207 5,593,959
Other creditors 633,706 462,883
Accruals and deferred income 3,852,459 5,180,152
25,500,019 31,985,343

17. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2016 2015
£    £   
Bank loans (see note 18) 174,527 286,988

18. LOANS

An analysis of the maturity of loans is given below:

2016 2015
£    £   
Amounts falling due within one year or on demand:
Advance from invoice discounting
company

15,041,806

19,284,459
Bank loans 112,484 109,421
15,154,290 19,393,880

Amounts falling due between two and five years:
Bank loans 174,527 286,988

The advance from the invoice discounting company of £15,041,806 (2015: £19,284,459) is secured by a
fixed and floating charge over the assets of the company.

Bank loans of £287,011 (2015: £396,409) relate to a loan from HSBC Bank Plc. Interest is charged at 2.25%
above the Bank of England base rate and the loan is repayable over 4 years. At the year end, this loan is
secured by fixed and floating charges over all assets and undertakings of the company.

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


19. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2016 2015
£    £   
Within one year 648,024 701,721
Between one and five years 1,881,133 1,947,361
In more than five years 217,188 651,563
2,746,345 3,300,645

The above minimum lease payments include amounts totalling £2,389,063 (2015: £2,814,887) which have
been guaranteed by Recruitment Express Limited, a company under common control.

20. PROVISIONS FOR LIABILITIES
2016 2015
£    £   
Deferred tax 54,000 82,000

Deferred
tax
£   
Balance at 1 January 2016 82,000
Decelerated capital allowances (25,000 )
Change in future tax rate (3,000 )
Balance at 31 December 2016 54,000

21. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2016 2015
value: £    £   
5,000 Ordinary 2p 100 100

The company has one class of ordinary shares which carry full rights with regards to voting participation
and dividends.

During 2013, options were issued to two of the directors, under the Enterprise Management Incentive
scheme, to acquire up to a combined total of 567 B Ordinary shares.

The options may be exercised, at an exercise price of £382 per share, in the event of a sale of the business
and in certain other instances as set out in the scheme rules, subject to certain conditions, within a period
of 10 years from the date on which the options were granted.

No options were exercised during the year under review.

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


22. RESERVES
Retained
earnings
£   

At 1 January 2016 3,506,632
Profit for the year 1,187,597
Dividends (1,400,000 )
At 31 December 2016 3,294,229

The company's retained earnings above represents cumulative profits or losses net of dividends paid and
other adjustments.

23. CONTINGENT LIABILITIES

At 31 December 2016 the company held bank facilities in a group with Recruitment Express Limited and
Group 24 Limited, companies under common control, in respect of loans from HSBC Invoice Finance (UK)
Limited. These were supported by cross guarantees, the total liability of which was £16,155,390 (2015:
£20,687,512) at the year end. Of this amount £15,041,806 (2015: £19,284,459) is included as a creditor
in these financial statements, £809,047 (2015: £1,131,241) is included as a creditor in the financial
statements of Recruitment Express Limited and £304,537 (2015: £271,812) is included as a creditor in the
financial statements of Group 24 Limited.

The company does not anticipate that this guarantee will be called upon.

24. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following loans to directors subsisted during the year ended 31 December 2016:

20162015
££

Balance outstanding at start of year58,74153,711
Amounts advanced575,302 63,332
Amounts repaid(516,135)(58,302)
Balance outstanding at end of year117,908 58,741


The above loans are interest free and repayable on demand.

ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 December 2016


25. RELATED PARTY DISCLOSURES

At 31 December 2016 the company was owed £214,625 by (2015: £2,493 owed to) Media Marketing
Research International Limited, a company controlled by Dr M H A Sacoor. During the year Media
Marketing Research International Limited recharged the company administrative expenses of £133,307
(2015: £108,566). A further £Nil (2015: £48,600) was charged by Media Marketing Research International
Limited for consultancy services.

At 31 December 2016 the company owed £816,378 (2015: £161,161) to Recruitment Express Limited, a
company controlled equally by Dr M H A Sacoor and M Sacoor. During the year the company recharged
administrative expenses of £1,508,448 (2015: £1,434,052) and cost of sales of £102,222 were recharged
by (2015 recharged to: £29,059) Recruitment Express Limited.

At 31 December 2016 the company owed £246,692 to (2015: £34,722 owed by) Group 24 Limited. During
the year, the company recharged administrative expenses to Group 24 Limited of £139,196 (2015:
£853,124) and Group 24 Limited recharged costs of sales of £1,607,501 (2015: £1,584,808) to the
company. Group 24 Limited is a company controlled equally by Dr M H A Sacoor and M Sacoor.

All of the related company balances referred to above are interest free and repayable on demand.

During the year, the company paid total dividends of £1,400,000 (2015: £1,270,000) to the shareholders
who are also directors.

26. POST BALANCE SHEET EVENTS

After the year end, the company took out an additional loan facility from HSBC Bank Plc of £3,000,000
repayable over two years. This facility is secured by fixed and floating charges over all the assets of the
company and by guarantees from Recruitment Express Limited and Group 24 Limited, companies under
common control. Two of the directors have also provided a personal guarantee limited to £1,000,000.
The company does not anticipate that these guarantees will be called upon.

27. ULTIMATE CONTROLLING PARTY

Control of the company is shared equally between Dr. M H A Sacoor and M Sacoor.